141 Besides, the phase IIb study of a novel granulocytemacrophage colony-stimulating factor (GM-CSF) receptor alpha monoclonal antibody, mavrilimumab, showed meaningful response by representing a novel mechanism
The main problem in COPD is damage to the lung tissue and chronic inflammation, which leads to difficulty breathing, chronic cough, wheezing, and reduced oxygen exchange
Most patients experience brief discomfort during or immediately after injection that resolves within minutes to hours
Originally developed in Australia in the 1990s, it was designed to harness the fat-burning properties of growth hormone without triggering its broader hormonal effects
Lung nodule diagnosis and cancer histology classification from computed tomography data by convolutional neural networks: a survey
This medicines product information is available in all official EU languages